| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/17/2004 | WO2004050098A1 Freeze-dried preparation of stabilized anthracycline compound |
| 06/17/2004 | WO2004050097A1 Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis |
| 06/17/2004 | WO2004050083A1 Iontophoretic delivery of rotigotine for the treatment of parkinson's disease |
| 06/17/2004 | WO2004050072A1 Water-soluble composition containing coenzyme q10 |
| 06/17/2004 | WO2004050069A1 Seamless center-filled capsules |
| 06/17/2004 | WO2004050068A1 Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
| 06/17/2004 | WO2004050067A1 PHARMACEUTICAL FORMULATIONS COMPRISING β-2 ADRENORECEPTOR AGONISTS AND XANTHINES |
| 06/17/2004 | WO2004050066A1 Microspheres and related processes and pharmaceutical compositions |
| 06/17/2004 | WO2004050065A1 Intraocular delivery compositions and methods |
| 06/17/2004 | WO2004050064A1 Method of manufacturing controlled release formulation using pelletizer |
| 06/17/2004 | WO2004050063A1 Quaternary compounds comprising propolis as the active substance |
| 06/17/2004 | WO2004050062A2 Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
| 06/17/2004 | WO2004050061A1 Microemulsion composition for oral administration of biphenyldimethyldicarboxylate |
| 06/17/2004 | WO2004050060A1 Drug delivery system using subconjunctival depot |
| 06/17/2004 | WO2004050059A1 Low viscosity liquid dosage forms |
| 06/17/2004 | WO2004050058A2 Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
| 06/17/2004 | WO2004050057A2 An exopolysaccharides delivery system for active molecules |
| 06/17/2004 | WO2004050056A1 Cochlear implant drug delivery device |
| 06/17/2004 | WO2004050034A2 Prolonged suppression of electrical activity in excitable tissues |
| 06/17/2004 | WO2004050028A2 Density-controlled particulate suspensions for foodstuff, cosmetic, pharmaceutical and other uses |
| 06/17/2004 | WO2004050027A2 Materials and methods for treating ocular-related disorders |
| 06/17/2004 | WO2004050021A2 Methods and compositions for applying pharmacologic agents to the ear |
| 06/17/2004 | WO2004050020A2 Improved opioid pharmaceutical compositions |
| 06/17/2004 | WO2004050019A2 Method and compositions for treating anxiety |
| 06/17/2004 | WO2004050012A2 Ifosfamide compositions for parenteral administration and a process for their preparation |
| 06/17/2004 | WO2004050011A2 High enantiomeric purity dexanabinol for pharmaceutical copositions |
| 06/17/2004 | WO2004050008A1 Process for producing edible orally administered agent of laminate film form and compression bonding apparatus |
| 06/17/2004 | WO2004049918A2 A system for administering a combination of therapies to a body lumen |
| 06/17/2004 | WO2004049907A2 Compositions and methods for treating transplants |
| 06/17/2004 | WO2004049904A2 Bioactive, resorbable scaffolds for tissue engineering |
| 06/17/2004 | WO2004049820A1 Water-based shellac coating material, process for producing the same, coated food obtained with the coating material, process for producing the same, coated medicine, process for producing the same, glazing composition for oily snack, method of glazing, and glazed oily snack |
| 06/17/2004 | WO2004043446A3 Combination product for controlling insect pests |
| 06/17/2004 | WO2004039360B1 Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| 06/17/2004 | WO2004032897A3 Pharmaceutical preparations, use of said preparations and method for increasing the bioavailability of medicaments for peroral administration |
| 06/17/2004 | WO2004028348A3 Cardiovascular anchoring device and method of deploying same |
| 06/17/2004 | WO2004024211A3 Method and device for painless injection of medication |
| 06/17/2004 | WO2004019870A3 Breath freshening and oral cleansing product using salicylaldehyde |
| 06/17/2004 | WO2004017907A3 Blood clot-targeted nanoparticles |
| 06/17/2004 | WO2004012651A3 Composition for heart disease, method to prepare same and uses thereof |
| 06/17/2004 | WO2004010941A3 Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| 06/17/2004 | WO2004002404A3 Compositions and method for enhanced mucosal delivery of interferon beta |
| 06/17/2004 | WO2003105781A3 Ophthalmic compositions for treating ocular hypertension |
| 06/17/2004 | WO2003101378A3 Pharmaceutical formulation in a drug delivery system and process for preparing the same |
| 06/17/2004 | WO2003063824A3 Pharmaceutical composition |
| 06/17/2004 | WO2003037405A8 Impedance sensor |
| 06/17/2004 | WO2003028700A3 Water soluble nanoparticles of hydrophilic and hydrophobic active materials |
| 06/17/2004 | WO2002102309A3 Formulation of lymphokines and method of use thereof for local or bath local and systemic control of proliferative cell disorders |
| 06/17/2004 | US20040117036 Prosthetic foot with tunable performance |
| 06/17/2004 | US20040117033 Method for composite cell-based implants |
| 06/17/2004 | US20040116992 Cardiovascular anchoring device and method of deploying same |
| 06/17/2004 | US20040116905 Flow restrictor with safety feature |
| 06/17/2004 | US20040116895 Device for inserting a needle-shaped body into living tissue |
| 06/17/2004 | US20040116847 Method and device for painless injection of medication |
| 06/17/2004 | US20040116652 Method for producing and using novel human defensins as biologically active proteins for treating infections and other diseases |
| 06/17/2004 | US20040116636 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 06/17/2004 | US20040116537 Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease |
| 06/17/2004 | US20040116534 Methods of treating and preventing narcolepsy using enantiomerically pure (s)-didesmethylsibutramine |
| 06/17/2004 | US20040116532 Isomers of 2-[(diphenylmethyl)sulfinyl] acetamide, including excipients such as diluents, binders or lubricants, used for prophylaxis of attention deficit disorder |
| 06/17/2004 | US20040116528 clear and stable solutions comprising alkali metal salts of 2-/3-benzoyl/phenylpropionic acidand optionally adjuvants, used as analgesics, antipyretics or antiinflammatory agents |
| 06/17/2004 | US20040116522 Medicinal solutions |
| 06/17/2004 | US20040116496 Asymmetric Disulfides and methods of using same |
| 06/17/2004 | US20040116395 Combinations for the treatment of inflammatory disorders |
| 06/17/2004 | US20040116392 obtaining such microparticles using a fluid-bed granulation technique; small size of the microparticles ensures a fast and predictable emptying from the stomach and controllable plasma levels of the absorbed drug |
| 06/17/2004 | US20040116380 enhance a host's immune defense mechanisms to infection but do not induce an inflammatory response |
| 06/17/2004 | US20040116360 Dissolving a polyene antibiotic and a poly(ethylene glycol)-phospholipid in a solvent to produce a solution; evaporating the solvent; adding water to the drug-polymer film and mixing vigorously, whereby micelles are formed |
| 06/17/2004 | US20040116352 Active substance combination containing a compound with an opioid effect and at least one further compound of formula 1 |
| 06/17/2004 | US20040116345 Novel albumin-free factor VIII formulations |
| 06/17/2004 | US20040115822 Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition |
| 06/17/2004 | US20040115766 Using thermophilic microorganisms as bioreactors for generating polypeptides for use treament of skin disorders; antitumor agens; antiaging agents |
| 06/17/2004 | US20040115615 Comprises amino acid sequences capable of inducing lymphadenopathy immune response without antagonizing cytotoxic lymphocytes; viricides and prevention of viral diseases |
| 06/17/2004 | US20040115612 Monochromatic fluid treatment systems |
| 06/17/2004 | US20040115433 Mixture of hydrophobic polymer core and nanoparticles; immobilization |
| 06/17/2004 | US20040115331 Suitable for inclusion in food |
| 06/17/2004 | US20040115305 Charging gum base components and all of the chewing gum additives into a mixing apparatus; operating the apparatus at atmospheric pressure to obtain the chewing gum, subject to the limitation that the gum base does not contain a vinyl polyester |
| 06/17/2004 | US20040115287 Hydrophobic active agent compositions and methods |
| 06/17/2004 | US20040115283 Administering parenterally a therapeutically effective amount of one or more arsenic compounds |
| 06/17/2004 | US20040115281 Microparticles |
| 06/17/2004 | US20040115279 For using common thermoplastic polymers to prepare thin-film microparticles having well-defined lateral geometries and other desired characteristics |
| 06/17/2004 | US20040115278 Particles, which are capable of binding, taking up and/or carrying the toxic and/or harmful substances, are removed from a body fluid in an extracorporeal step or in an extrinsic or exogeneous device |
| 06/17/2004 | US20040115277 Microparticles with an improved release profile and method for the production thereof |
| 06/17/2004 | US20040115276 Liquid pharmaceutical for oral delivery |
| 06/17/2004 | US20040115275 Embedded with physiologically active substances; raw materials for producing the particles are inexpensive, quality and appearance are uniform |
| 06/17/2004 | US20040115274 Antimicrobial containing solventless hot melt adhesive composition |
| 06/17/2004 | US20040115272 Stability and dissolvability; for the therapy of an infectious disease |
| 06/17/2004 | US20040115271 Hydration compositions for corneal pre-surgery treatment |
| 06/17/2004 | US20040115268 To provide sustained delivery of a therapeutic agent for treating a patient, e.g., human, to obtain a desired local or systemic physiological or pharmacological effect |
| 06/17/2004 | US20040115267 Both active substances are contained in the same administration unit as two separately formulated subunits |
| 06/17/2004 | US20040115265 Minimal physical and chemical incompatibility (including minimal pravastatin:aspirin interaction), and reduced side effects normally associated with use of such drugs |
| 06/17/2004 | US20040115264 Bioavailability |
| 06/17/2004 | US20040115263 Administering therapeutically effective amount of bupropion or pharmaceutically acceptable salts thereof |
| 06/17/2004 | US20040115262 Formulations and dosage forms for controlled delivery of topiramate |
| 06/17/2004 | US20040115261 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 06/17/2004 | US20040115260 cefquinome and a prolonged release vehicle characterised in that the prolonged release vehicle comprises a mixture of an oil and aluminium distearate |
| 06/17/2004 | US20040115259 a floating tablet including as active principle alfuzosin |
| 06/17/2004 | US20040115258 cyclodextrin can be effective to mask the taste of pharmaceutically active agents without the formulation of inclusion complexes between the cyclodextrin and the active agent |
| 06/17/2004 | US20040115257 Retinoid agent capsule system |
| 06/17/2004 | US20040115256 novel formulation or composition of a pharmaceutically acceptable polymer and suitable excipients to be used for injection molding of the capsules or multi-component dosage forms |
| 06/17/2004 | US20040115255 Method and composition for solubilising a biologically active compound with low water solubility |
| 06/17/2004 | US20040115254 Microcapsules and methods of use |
| 06/17/2004 | US20040115253 Veterinary delivery systems and methods of delivering effective agents to animals |